Assignee
TAIHO PHARMACEUTICAL CO LTD
JP·258 granted patents·91 pending applications·1,940 citations·filing 1971–2025
Top patents by PatentIndex Score
349 records- 0195US4562073APenicillin derivativesTAIHO PHARMACEUTICAL CO LTD·Filed 1983·Granted Dec 31, 1985·57 cites·18 claims
- 0295US4452813ASulfonate derivatives, process for preparing same and antilipemic compositions containing the derivativeTAIHO PHARMACEUTICAL CO LTD·Filed 1982·Granted Jun 5, 1984·65 cites·2 claims
- 0394US6660742B2Compositions and methods of the use thereof achiral analogues of CC-1065 and the duocarmycinsTAIHO PHARMACEUTICAL CO LTD·Filed 2001·Granted Dec 9, 2003·123 cites·14 claims
- 0494US5521202AThiazolidine derivatives and pharmaceutical compositions containing the sameTAIHO PHARMACEUTICAL CO LTD·Filed 1994·Granted May 28, 1996·70 cites·6 claims
- 0593US10155768B2Fused pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 18, 2018·8 cites·9 claims
- 0693US7799783B2Method of administrating an anticancer drug containing α, α, α-trifluorothymidine and thymidine phosphorylase inhibitorTAIHO PHARMACEUTICAL CO LTD·Filed 2005·Granted Sep 21, 2010·15 cites·12 claims
- 0793US5480899AOxazolidine derivatives and pharmaceutically acceptable salts thereofTAIHO PHARMACEUTICAL CO LTD·Filed 1993·Granted Jan 2, 1996·72 cites·11 claims
- 0892US11078207B2Substituted pyrrolo[2,3-d]pyrimidines as HER2 inhibitorsTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Granted Aug 3, 2021·4 cites·19 claims
- 0992US9920060B2Pyrazolo[3,4-d]pyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2017·Granted Mar 20, 2018·21 cites·8 claims
- 1092US6479500B1Agents for alleviating side effectsTAIHO PHARMACEUTICAL CO LTD·Filed 2000·Granted Nov 12, 2002·45 cites·4 claims
- 1192US5990139AThiazolidinedione derivatives or salts thereof and pharmaceutical compositions containing the sameTAIHO PHARMACEUTICAL CO LTD·Filed 1996·Granted Nov 23, 1999·65 cites·8 claims
- 1291US11191759B2Therapeutic agent for fibrosisTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 7, 2021·2 cites·7 claims
- 1391US11110062B2Pharmaceutical compositionTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Granted Sep 7, 2021·3 cites·18 claims
- 1491US5744475AUracil derivatives, and antitumor effect potentiator and antitumor agent containing the sameTAIHO PHARMACEUTICAL CO LTD·Filed 1996·Granted Apr 28, 1998·47 cites·14 claims
- 1591US4556737ASulfonium compounds, processes for preparing the compounds and pharmacological composiitons containing the sameTAIHO PHARMACEUTICAL CO LTD·Filed 1984·Granted Dec 3, 1985·39 cites·9 claims
- 1690US10835536B2Therapeutic agent for FGFR inhibitor-resistant cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 17, 2020·5 cites·31 claims
- 1790US7785612B2Polyamino acid for use as adjuvantTAIHO PHARMACEUTICAL CO LTD·Filed 2006·Granted Aug 31, 2010·6 cites·4 claims
- 1890US7157459B2Postoperative adjuvant chemotherapy with UFTTAIHO PHARMACEUTICAL CO LTD·Filed 2005·Granted Jan 2, 2007·31 cites·4 claims
- 1989US10889555B2Sulfonamide compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Granted Jan 12, 2021·3 cites·18 claims
- 2089US10124003B2Therapeutic agent for FGFR inhibitor-resistant cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2014·Granted Nov 13, 2018·8 cites·8 claims
- 2189US5206261AOxindole derivativeTAIHO PHARMACEUTICAL CO LTD·Filed 1990·Granted Apr 27, 1993·48 cites·7 claims
- 2288US10695340B2Therapeutic agent for fibrosisTAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 30, 2020·2 cites·8 claims
- 2388US8889666B2Quinolyl pyrrolo pyrimidyl condensed-ring compound and salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2013·Granted Nov 18, 2014·6 cites·9 claims
- 2487US10723742B2Biphenyl compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2016·Granted Jul 28, 2020·5 cites·10 claims
- 2587US7417175B2Interstitial prostatism model animalTAIHO PHARMACEUTICAL CO LTD·Filed 2002·Granted Aug 26, 2008·53 cites·3 claims
- 2686US10456399B2Method for treating cancer patients with severe renal impairmentTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 29, 2019·4 cites·30 claims
- 2786US6717002B2Method of producing steroid derivativesTAIHO PHARMACEUTICAL CO LTD·Filed 2001·Granted Apr 6, 2004·35 cites·3 claims
- 2886US6159969AUracil derivatives, and antitumor effect potentiator and antitumor agent containing the sameTAIHO PHARMACEUTICAL CO LTD·Filed 1998·Granted Dec 12, 2000·31 cites·14 claims
- 2986US4529592APenicillin derivativesTAIHO PHARMACEUTICAL CO LTD·Filed 1983·Granted Jul 16, 1985·20 cites·17 claims
- 3086US4496484APenicillin derivativesTAIHO PHARMACEUTICAL CO LTD·Filed 1983·Granted Jan 29, 1985·18 cites·8 claims
- 3185US10449189B2Therapeutic agent for fibrosisTAIHO PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 22, 2019·2 cites·11 claims
- 3285US10143688B2Mesylic acid salt of acylthiourea compound, crystal of the same, and process for producing theseTAIHO PHARMACEUTICAL CO LTD·Filed 2016·Granted Dec 4, 2018·3 cites·20 claims
- 3385US9375434B2Antitumor effect potentiator composed of imidazooxazine compoundTAIHO PHARMACEUTICAL CO LTD·Filed 2013·Granted Jun 28, 2016·4 cites·12 claims
- 3485US5733918ACondensed-Indan derivatives and pharmaceutically acceptable salts thereofTAIHO PHARMACEUTICAL CO LTD·Filed 1995·Granted Mar 31, 1998·32 cites·16 claims
- 3584US11883404B2Preparation and composition for treatment of malignant tumorsTAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jan 30, 2024·2 cites·13 claims
- 3684US10849886B2Combination therapy using azabicyclo compound for cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2017·Granted Dec 1, 2020·2 cites·11 claims
- 3784US9616081B2Antitumor agent including low-dose irinotecan hydrochloride hydrateTAIHO PHARMACEUTICAL CO LTD·Filed 2014·Granted Apr 11, 2017·7 cites·20 claims
- 3884US9012475B2Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumorTAIHO PHARMACEUTICAL CO LTD·Filed 2013·Granted Apr 21, 2015·4 cites·12 claims
- 3984US5710162ACondensed-indan derivatives and pharmaceutically acceptable salts thereofTAIHO PHARMACEUTICAL CO LTD·Filed 1996·Granted Jan 20, 1998·29 cites·13 claims
- 4083US12037345B2Heterobicyclic compounds for inhibiting the activity of SHP2TAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jul 16, 2024·2 cites·19 claims
- 4183US9108973B23,5-disubstituted alkynylbenzene compound and salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2013·Granted Aug 18, 2015·8 cites·10 claims
- 4282US10960004B2Method for treating cancer patients with severe renal impairmentTAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Mar 30, 2021·2 cites·30 claims
- 4382US9963456B2Pyrrolopyrimidine compound or salt thereof and compositions containing the pyrrolopyrimidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2015·Granted May 8, 2018·2 cites·4 claims
- 4482US9694001B2Combination therapy using azabicyclo compound for cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2014·Granted Jul 4, 2017·6 cites·14 claims
- 4582US5869246ATriplex Oligonucleotides targeted to p120TAIHO PHARMACEUTICAL CO LTD·Filed 1995·Granted Feb 9, 1999·62 cites·6 claims
- 4682US2024156792A1Combination therapy using azabicyclo compound for cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 4782US2024148730A1Method for treating cancer patients with severe renal impairmentTAIHO PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 4881US11166943B2Combination therapy using azabicyclo compound for cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2020·Granted Nov 9, 2021·1 cites·11 claims
- 4981US10894048B2Antitumor drug for intermittent administration of FGFR inhibitorTAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jan 19, 2021·4 cites·18 claims
- 5081US6028079ACondensed-indan derivatives and pharmaceutically acceptable salts thereofTAIHO PHARMACEUTICAL CO LTD·Filed 1997·Granted Feb 22, 2000·23 cites·2 claims
Showing the top 50 of 349 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when TAIHO PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →